• According to Transparency Market Research’s latest report on the global transcatheter embolization and occlusion devices market for the historical period 2017–2018 and forecast period 2019–2027. Rise in prevalence of chronic diseases, technological advancements, increase in patient awareness and health care expenditure, and surge in need of treatment of complex diseases drive the global market during the forecast period.
  • According to the report, the global transcatheter embolization and occlusion devices market was valued at US$ 2,957.4 Mn in 2018 and is anticipated to expand at a CAGR of 7.8 % from 2019 to 2027. In terms of volume, the global transcatheter embolization devices were accounted at 73,92,954 units in 2018. 
fa global transcatheter embolization occlusion devices market

To know the scope of our report Get a Sample on Transcatheter Embolization and Occlusion Devices Market

Increase in Spectrum of Transcatheter Embolization in Gynecologic and Obstetric Indications: Key Drivers

  • Transcatheter embolization is a useful therapeutic option for a wide range of gynecologic and obstetric abnormalities. Transcatheter embolization procedures performed with the use of radiologic imaging for guidance are minimally invasive and could prevent surgery, thereby decreasing morbidity and mortality and conserving a patient’s future fertility potential.
  • Under experienced interventional radiologists and essential technical support, transcatheter embolization can be performed for the treatment of numerous lesions in the female pelvis, including obstetric-gynecologic hemorrhage, advanced-stage malignancy, ectopic pregnancy, and arteriovenous malformation. It can also be used to treat pelvic congestion syndrome and symptomatic uterine fibroids in women who have undergone appropriate screening. Global success rate of 85% and higher have been reported in women treated with embolization for uterine fibroids.

Get a glimpse of the in-depth analysis through our Report Brochure

Development of New Materials for Catheterization and Embolization Boost Market Growth

  • As new materials for catheterization and embolization are developed, to provide greater vascular occlusion with regard to clinical performance and lower the complication rates. Many new agents have appeared on the market in the past several years.
  • Liquid embolic agents under investigation are primarily targeted toward the treatment of aneurysms, AVMs, and HCC. The administration of currently available liquid embolic polymers, NBCA, Onyx, and PHIL are associated with the introduction of toxic compounds. Hence, several groups are investigating new in situ gelling polymer systems that avoid the use of toxic byproducts or solvents.
  • The number of flow-directed embolic materials is expanding. The microspheres are prepared using a suspension polymerization process of poly(lactide-co-glycolide)-block-poly(ethylene glycol) crosslinker and PEGMA monomer. Co-monomers methacrylic acid (MA) and 2-methylene-1,3-dioxepane (MDO) were integrated to refine its properties.

Post Embolization Syndrome to Hamper Market

  • Embolization is a useful technique in the therapeutic management of patients with vascular injuries caused by trauma, liver surgery, or percutaneous procedures. Such injuries are unusual; however, the presence of hemobilia or hemoperitoneum resulting from pseudoaneurysm or laceration of a blood vessel could put a patient critically at risk. Selective embolization of the injury provides excellent results as far as hemostasis is concerned (86%), although an associated morbidity of 58% has been described, which is basically connected with bile leakage, liver abscesses, and/or necrosis. Such lesions should, therefore, be treated on an individual basis, with full awareness of the possible consequences of a technique that is not risk-free.
  • The most common complication after embolization, the cause of which is still not properly understood, is the occurrence of fever, pain in the right hypochondrium, and a rise in transaminases. High temperature (< 38.5°C) may occur between 41% and 74% of cases and seems to be related to the presence of necrosis of the tumor and healthy tissue. Cytolysis (increase in transaminases), which has been observed in up to 93% of cases, is related to damage to healthy (noncancerous) hepatocytes.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Transcatheter Embolization and Occlusion Devices Market: Competitive Landscape

  • This report profiles major players in the global transcatheter embolization and occlusion devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global transcatheter embolization and occlusion devices market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global transcatheter embolization and occlusion devices market are
    • BTG plc
    • Boston Scientific Corporation
    • Medtronic plc
    • Penumbra, Inc.
    • Cook Medical
    • Edwards Lifesciences Corporation
    • Merit Medical Systems
    • Johnson & Johnson Services, Inc.
    • Pfizer, Inc.
    • Stryker Corporation
    • Terumo Corporation
    • Sirtex Medical Limited
    • Abbott Laboratories.

Global Transcatheter Embolization and Occlusion Devices Market: Key Developments

Key players in the global transcatheter embolization and occlusion devices market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global transcatheter embolization and occlusion devices market. A few expansion strategies adopted by players operating in the global transcatheter embolization and occlusion devices market are:

  • In October 2017, BTG plc announced the acquisition of Roxwood Medical, a manufacturer of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease.
  • In October, 2017, Boston Scientific Corporation completed the acquisition of Apama Medical Inc. (Apama), a privately-held company developing the Apama Radiofrequency single-shot Balloon Catheter System for the treatment of atrial fibrillation.
  • In January 2017, Ethicon Endo-Surgery, Inc., a subsidiary of Johnson and Johnson, announced the acquisition of Megadyne Medical Products, Inc., a privately-held medical devices company that develops, manufactures, and markets electrosurgical tools used in operating rooms across the globe.

The report on the global transcatheter embolization and occlusion devices market discussed individual strategies, followed by company profiles of manufacturers of transcatheter embolization and occlusion devices. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global transcatheter embolization and occlusion devices market.

TMR’s report on the global transcatheter embolization and occlusion devices market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue (US$ Mn) and volume (Units) of the global transcatheter embolization and occlusion devices market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global transcatheter embolization and occlusion devices market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global transcatheter embolization and occlusion devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global transcatheter embolization and occlusion devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global transcatheter embolization and occlusion devices market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global transcatheter embolization and occlusion devices market.

The report delves into the competitive landscape of the global transcatheter embolization and occlusion devices market. Key players operating in the global transcatheter embolization and occlusion devices market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global transcatheter embolization and occlusion devices market that have been profiled in this report.

Key Questions Answered in Global Transcatheter Embolization and Occlusion Devices Market Report

  • What is the scope of product companies in the global transcatheter embolization and occlusion devices market?
  • What will be the Y-o-Y growth of the global transcatheter embolization and occlusion devices market between 2019 and 2027?
  • How many transcatheter embolization and occlusion device were used in 2018 across the globe?
  • What is the influence of changing trends in technologies on the global transcatheter embolization and occlusion devices market?
  • Will North America continue to be the most profitable market for transcatheter embolization and occlusion devices providers?
  • Which factors are anticipated to hamper the growth of the global transcatheter embolization and occlusion devices market during the forecast period?
  • Which are the leading companies in the global transcatheter embolization and occlusion devices market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global transcatheter embolization and occlusion devices market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global transcatheter embolization and occlusion devices market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the transcatheter embolization and occlusion devices market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the transcatheter embolization and occlusion devices market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global transcatheter embolization and occlusion devices market with accuracy. The study also uses the top-down approach to assess the revenues (US$ Mn) and volume (units) for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global transcatheter embolization and occlusion devices market more reliably and accurately.

Regional Segmentation of Transcatheter Embolization and Occlusion Devices Market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Global Transcatheter Embolization and Occlusion Devices Market - Segmentation

Product

Embolization Coils

Coiling Assist Devices

Embolization Particles

Flow Diverter Devices

Liquid Embolics

Accessories

Application

Peripheral Vascular Disease

Neurology

Oncology

Urology

Others

End-user

Hospitals

Ambulatory Surgical Centers

Clinics

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Transcatheter Embolization Occlusion Devices Market

Buy Now